search
Back to results

Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Adult Volunteers

Primary Purpose

Pre Eclampsia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Sphygmo: Automatic Blood Pressure Monitor
GE Dinamap ProCare Automatic Blood Pressure Monitor
Sponsored by
William Marsh Rice University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional device feasibility trial for Pre Eclampsia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 18 years of age or older
  • Willing and able to provide informed consent

Exclusion Criteria:

  • Unable to provide informed consent

Sites / Locations

  • Rice University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Healthy Adults Volunteers

Arm Description

Men and women over the age of 18 will have their blood pressure measured with both the Sphygmo: Automatic Blood Pressure Monitor device and the GE Dinamap ProCare automatic blood pressure monitor.

Outcomes

Primary Outcome Measures

Accuracy of Blood Pressure Measurement by Sphygmo Relative to the Clinical Standard.
Mean difference of systolic and diastolic blood pressure readings between Sphygmo device and the gold standard sphygmomanometer.
Percentage of Sphygmo Readings That Were With < 5 mmHg, < 10 mmHg, and < 15 mmHg of the Readings by the Gold Standard Sphygmomanometer.
The British Hypertension society defines a specific criteria for the accuracy of a sphygmomanometer. Devices are graded according to the cumulative percentage of readings that have an absolute difference between the more favorable observer's mercury sphygmomanometer readings and the test device of < 5 mmHg, < 10 mmHg, and < 15 mmHg. A letter grade of "A" requires that over 60%, 85%, and 95% were achieved in the < 5 mmHg, < 10 mmHg, and <15 mmHg categories, respectively. A letter grade of "B" requires that over 50%, 75%, and 90% were achieved in the < 5 mmHg, < 10 mmHg, and <15 mmHg categories, respectively. The test device achieved a grade of (B/B) with the validation data from this study.

Secondary Outcome Measures

Full Information

First Posted
October 9, 2014
Last Updated
March 4, 2020
Sponsor
William Marsh Rice University
search

1. Study Identification

Unique Protocol Identification Number
NCT02267577
Brief Title
Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Adult Volunteers
Official Title
Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Adult Volunteers
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
January 2015 (undefined)
Primary Completion Date
October 2015 (Actual)
Study Completion Date
October 12, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
William Marsh Rice University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The research team has developed an automatic blood pressure monitor (Sphygmo) to be used for the monitoring and diagnosis of pre-eclampsia in pregnant women, particularly in low-resource settings where current monitoring is limited. 90 adult volunteers will be enrolled by researchers at Rice University. The participant will be seated in a comfortable chair with arm at heart level. Arm circumference will be measured and a blood pressure cuff will be placed on the arm. The cuff will be inflated and blood pressure measurements will be taken by a commercially available device and by the Sphygmo device. Blood pressure measurements from both devices will be recorded. The participant's blood pressure will be measured up to 9 times with a waiting period of 45-60 seconds between each measurement. The results of this study will be used to optimize the blood pressure detection algorithm and thus further develop the device.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pre Eclampsia

7. Study Design

Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Participants enrolled in the study will have their blood pressure measured multiple times with both the GE Dinamap Procare commercial blood pressure monitor and Sphygmo, the experimental blood pressure monitoring device.
Masking
None (Open Label)
Allocation
N/A
Enrollment
90 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Healthy Adults Volunteers
Arm Type
Experimental
Arm Description
Men and women over the age of 18 will have their blood pressure measured with both the Sphygmo: Automatic Blood Pressure Monitor device and the GE Dinamap ProCare automatic blood pressure monitor.
Intervention Type
Device
Intervention Name(s)
Sphygmo: Automatic Blood Pressure Monitor
Intervention Description
A team of engineers from Rice University has recently developed Sphygmo, an ambulatory, low-cost blood pressure monitor for use in the diagnosis and management of pre-eclampsia in low-resource hospitals.
Intervention Type
Device
Intervention Name(s)
GE Dinamap ProCare Automatic Blood Pressure Monitor
Intervention Description
This commercially available gold standard blood pressure monitor will be used as a control to assess the accuracy of the Sphygmo device.
Primary Outcome Measure Information:
Title
Accuracy of Blood Pressure Measurement by Sphygmo Relative to the Clinical Standard.
Description
Mean difference of systolic and diastolic blood pressure readings between Sphygmo device and the gold standard sphygmomanometer.
Time Frame
Blood pressure was measured an average of 9 times for each participant during their single visit and the mean of these measurements was recorded and used for analysis. The measurement period lasted approximately 30-45 minutes.
Title
Percentage of Sphygmo Readings That Were With < 5 mmHg, < 10 mmHg, and < 15 mmHg of the Readings by the Gold Standard Sphygmomanometer.
Description
The British Hypertension society defines a specific criteria for the accuracy of a sphygmomanometer. Devices are graded according to the cumulative percentage of readings that have an absolute difference between the more favorable observer's mercury sphygmomanometer readings and the test device of < 5 mmHg, < 10 mmHg, and < 15 mmHg. A letter grade of "A" requires that over 60%, 85%, and 95% were achieved in the < 5 mmHg, < 10 mmHg, and <15 mmHg categories, respectively. A letter grade of "B" requires that over 50%, 75%, and 90% were achieved in the < 5 mmHg, < 10 mmHg, and <15 mmHg categories, respectively. The test device achieved a grade of (B/B) with the validation data from this study.
Time Frame
Blood pressure was measured an average of 9 times for each participant during their single visit and the mean of these measurements was recorded and used for analysis. The measurement period lasted approximately 30-45 minutes.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 18 years of age or older Willing and able to provide informed consent Exclusion Criteria: Unable to provide informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rebecca R Kortum, PhD
Organizational Affiliation
William Marsh Rice University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rice University
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Adult Volunteers

We'll reach out to this number within 24 hrs